ArticleClinical kidney journal2022

Minimal change disease with thrombotic microangiopathy following the Pfizer-BioNTech COVID-19 vaccine.

Fumika Tanaka et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.